Qinwei Chen
Impact in
-
- Acute Myeloid Leukemia Research
Papers in
-
- Histone Deacetylase Inhibitors Research 7
- Protein Degradation and Inhibitors 5
- Epigenetics and DNA Methylation 4
-
- Acute Myeloid Leukemia Research 6
- Co-authors
- Bing Xu (6 shared papers)Yi Qiu (3 shared papers)Yin Li (1 shared paper)Bowen Yan (3 shared papers)Jie Zha (5 shared papers)Bing Xu (4 shared papers)Zhihong Fang (3 shared papers)Manman Deng (8 shared papers)
- Journals
- Blood (3 papers)European Journal of Pharmacology (3 papers)Leukemia (2 papers)Clinical Epigenetics (1 paper)Cell Genomics (1 paper)
- Partner nations
- ChinaUnited StatesSlovenia
In The Last Decade
Qinwei Chen
25 papers receiving 284 citations
Peers
Comparison fields: 5 of 72
- Hematology 60
- Nephrology 21
- Cancer Research 42
- Health 21
- Modeling and Simulation 10
Countries citing papers authored by Qinwei Chen
This map shows the geographic impact of Qinwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinwei Chen more than expected).
Fields of papers citing papers by Qinwei Chen
This network shows the impact of papers produced by Qinwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinwei Chen. The network helps show where Qinwei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Qinwei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 48 | |
| 2 | 2018 | 43 | |
| 3 | 2019 | 38 | |
| 4 | 2022 | 24 | |
| 5 | 2020 | 23 | |
| 6 | 2018 | 15 | |
| 7 | 2021 | 15 | |
| 8 | 2021 | 12 | |
| 9 | 2024 | 8 | |
| 10 | 2019 | 8 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2025 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2020 | 3 | |
| 20 | 2008 | 2 |
About Qinwei Chen
Qinwei Chen is a scholar working on Molecular Biology, Hematology, Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 28 papers that have together received 285 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (7 papers), Acute Myeloid Leukemia Research (6 papers), Protein Degradation and Inhibitors (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer Genomics and Diagnostics (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Recycling and Waste Management Techniques (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Hematology (60 citations), Nephrology (21 citations), Cancer Research (42 citations), Health (21 citations) and Modeling and Simulation (10 citations). Qinwei Chen has collaborated with scholars based in China, United States and Slovenia. Frequent co-authors include Bing Xu, Yi Qiu, Yin Li, Bowen Yan, Jie Zha, Bing Xu, Zhihong Fang, Manman Deng, Ming Tang and Yuanfei Shi. Their work appears in journals such as Blood, European Journal of Pharmacology, Leukemia, Clinical Epigenetics and Cell Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.